Results 81 to 90 of about 4,657,009 (154)

Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan

Drug, Healthcare and Patient Safety
Akina Takami,1 Gen Terashima,2 Takumi Tajima,2 Koki Yamashita,3 Ataru Igarashi1 1Department of Health Policy and Public Health, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan; 2JMDC, Inc., Tokyo, Japan; 3Maxwell ...
Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A   +4 more
doaj  

Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism

Thrombosis Journal
Background Direct oral anticoagulants are the established drugs for treating pulmonary thromboembolism. The advantage of direct oral anticoagulants over conventional therapy for clot lysis and right ventricular unloading in the acute phase remains ...
Hiroya Hayashi, Akihiro Tsuji, Akiyuki Kotoku, Hiroyuki Endo, Naruhiro Nishi, Takatoyo Kiko, Ryotaro Asano, Jin Ueda, Tatsuo Aoki, Tetsuya Fukuda, Takeshi Ogo   +10 more
doaj   +1 more source

Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications

Patients at extremes of body weight are underrepresented in randomized controlled trials of direct-acting oral anticoagulants (DOACs).
Rosa Talerico, Frederikus Albertus Klok, Roberto Pola, Menno Volkert Huisman   +3 more
core   +1 more source

Impact of cancer on bleeding and ischemic stroke in atrial fibrillation patients taking rivaroxaban, a direct oral anticoagulant

主査 : 諸井雅男 / タイトル : Impact of cancer on bleeding and ischemic stroke in atrial fibrillation patients taking rivaroxaban, a direct oral anticoagulant /著者 : Katsuya Akitsu, Rine Nakanishi, Toshio Kinoshita, Hitomi Yuzawa, Tadashi Fujino, Takanori Ikeda ...
Katsuya, Akitsu, 秋津, 克哉, アキツ, カツヤ   +2 more
core  

Direct Oral Anticoagulant Levels in Clinical Practice – A Scoping Review of the Literature

Oral anticoagulation therapy is used for the prevention of stroke in patients with atrial fibrillation (AF) and direct oral anticoagulants (DOACs) now account for most oral anticoagulant use (1,2).
Jerrold Levy, Risa Shorr, Athavan Murugaananthan, Jean Connors, Karen Moffat, Jonathan Douxfils, Marc Carrier, Joseph Shaw, Deborah Siegal, Siraj Mithoowani, James Douketis, Yan Xu, Pooja Narula   +12 more
core   +1 more source

Perioperative management of direct oral anticoagulant-treated patients who need urgent surgery. [PDF]

Res Pract Thromb Haemost
Carlin S, Godoy A, Douketis J.
europepmc   +1 more source

Clinical decision support tool evaluation: Correction of direct oral anticoagulant dosing errors by clinical pharmacists and physicians. [PDF]

Res Pract Thromb Haemost
Saraswat A, Smith SN, Dorsch MP, Fabbri M, Seagull J, Choi SY, Lanham M, Barnes GD.   +7 more
europepmc   +1 more source

Comparison of monthly bleeding rates after direct oral anticoagulant initiation for venous thromboembolism and atrial fibrillation. [PDF]

Res Pract Thromb Haemost
Awuah D, Zestos S, Errickson J, Kong X, Ali M, Giuliano C, Haymart B, Kaatz S, DeCamillo D, Ryan N, Sood S, Froehlich JB, Barnes GD, Schaefer JK.   +13 more
europepmc   +1 more source

Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake: toward evidence-informed care. [PDF]

Front Neurol
Zupan M, Šabovič M, Kermer P, Frol S.
europepmc   +1 more source

Extended treatment for venous thromboembolism: Is direct oral anticoagulant dose-reduction better for all? [PDF]

Hemasphere
Lauw MN, Middeldorp S, Carrier M.
europepmc   +1 more source